MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference

A live webcast of MediWound’s presentation will be available on its website under Investors > Events & Presentations.

Rhea-AI Summary

MediWound (MDWD)/b) will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026, at 2:00 p.m. ET.The event will be held at the Lotte New York Palace Hotel in New York City, moderated by Swayampakula Ramakanth of H.C. Wainwright. A live webcast will be accessible on MediWound’s website under Investors > Events & Presentations.

Argus Sep 2 session

+3.49% close to close Open Argus

Details

News Market Reaction – MDWD

On Sep 2, the day this news came out, MDWD closed 3.49% above the previous close.

Data tracked by StockTitan Argus for the Sep 2 session.

Key Figures

Conference edition: 28th Conference dates: September 14–16, 2026 Fireside chat date: September 14, 2026 +1 more

Conference edition

28th

H.C. Wainwright Global Investment Conference

Conference dates

September 14–16, 2026

H.C. Wainwright Global Investment Conference

Fireside chat date

September 14, 2026

MediWound fireside chat

Fireside chat time

2:00 p.m. ET

September 14, 2026

Historical Context

5 past events · Latest: Aug 13

5 events

1. Aug 13

   Second-quarter earnings

   24h Move

   -2.7%

   Lower revenue and wider operating losses accompanied reaffirmed full-year guidance

2. Jul 29

   Earnings date notice

   24h Move

   -1.9%

   Company scheduled second-quarter results and a management conference call

3. May 27

   First-quarter earnings

   24h Move

   -14.1%

   Revenue declined and net loss widened despite reaffirmed full-year guidance

4. May 07

   Earnings date notice

   24h Move

   -0.6%

   Company announced first-quarter results date and webcast arrangements

5. Apr 13

   Expert consensus update

   24h Move

   -1.1%

   U.S. expert consensus supported earlier less-invasive chronic-wound debridement

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

biologic, eschar, debridement

3 terms

biologic medical

"The company’s FDA-approved biologic, NexoBrid®, is indicated"

A biologic is a medicine made from living cells or organisms—such as proteins, antibodies or vaccines—rather than being chemically synthesized. Investors watch biologics closely because they are expensive and complex to develop and manufacture, often enjoy strong market pricing and protections, and face unique regulatory and supply risks; think of them like handcrafted specialty goods versus mass-produced items with higher potential reward and higher production risk.

eschar medical

"for the enzymatic removal of eschar in thermal burns"

A dry, dark scab of dead tissue that forms over a wound or ulcer when skin cells and blood supply have been damaged; it’s the crusty layer doctors inspect to judge healing or infection. For investors, eschar matters in healthcare contexts because its presence, size, or changes can signal how well a treatment, device or wound-care product is working, or indicate complications that may affect clinical outcomes and regulatory reviews.

debridement medical

"EscharEx®, is an investigational therapy for the debridement of chronic wounds"

Debridement is the medical removal of dead, infected, or damaged tissue and foreign material from a wound to promote healing, similar to pruning dead branches so new growth can flourish. For investors, it matters because how debridement is performed — by drugs, devices, dressings, or procedures — affects clinical outcomes, product demand, reimbursement decisions, regulatory approval pathways, and the financial prospects of companies offering those solutions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MediWound to Present at the H.C. Wainwright 28^th Annual Global Investment Conference

YAVNE, Israel, September 2, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that Ofer Gonen, Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference. The conference will take place September 14–16, 2026, at the Lotte New York Palace Hotel in New York City.

The fireside chat, moderated by Swayampakula Ramakanth, Managing Director and Senior Healthcare Analyst at H.C. Wainwright, is scheduled for Monday, September 14, 2026, at 2:00 p.m. ET.

A live webcast of the fireside chat will be available here and on MediWound’s website under the Events & Presentations page in the Investors section.

About MediWound

MediWound Ltd. (Nasdaq: MDWD) is a global biotechnology company pioneering enzymatic, non-surgical therapies for tissue repair. The company’s FDA-approved biologic, NexoBrid^®, is indicated for the enzymatic removal of eschar in thermal burns and is marketed in the United States, the European Union, Japan, and additional international markets. MediWound’s late-stage pipeline product, EscharEx^®, is an investigational therapy for the debridement of chronic wounds, with the potential to become, if approved, a new standard of care in wound management.

For more information, visit www.mediwound.com and follow us on LinkedIn and X (formerly Twitter).

MediWound Contacts:
Hani Luxenburg Chief Financial Officer MediWound Ltd. ir@mediwound.com		Daniel Ferry Managing Director LifeSci Advisors, LLC daniel@lifesciadvisors.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will MediWound (MDWD) present at the H.C. Wainwright 28th Annual Global Investment Conference?

MediWound’s CEO, Ofer Gonen, is scheduled to participate in a fireside chat on Monday, September 14, 2026, at 2:00 p.m. ET during the H.C. Wainwright 28th Annual Global Investment Conference.

Where is the H.C. Wainwright 28th Annual Global Investment Conference featuring MediWound (MDWD) being held?

The conference, where MediWound’s CEO will join a fireside chat, will take place on September 14–16, 2026, at the Lotte New York Palace Hotel in New York City.

How can investors access the MediWound (MDWD) fireside chat webcast from the H.C. Wainwright conference?

A live webcast of the fireside chat will be available via an online link and on MediWound’s website under the Investors section, on the Events & Presentations page.

Who will represent MediWound (MDWD) at the H.C. Wainwright 28th Annual Global Investment Conference fireside chat?

MediWound’s Chief Executive Officer, Ofer Gonen, will participate in the fireside chat, which will be moderated by Swayampakula Ramakanth, Managing Director and Senior Healthcare Analyst at H.C. Wainwright.